We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Bipolar Probes for Radiofrequency Thermotherapy

By HospiMedica staff writers
Posted on 05 Sep 2000
New bipolar probes for administering radio frequency-induced interstitial thermotherapy (RFITT) provide surgeons with highly accurate and unusually gentle operating instruments for ear, nose, and throat patients, says the developer. More...
RFITT can be used to treat such conditions as obstructive sleep apnea, nasal polyps, and to serve as palliative tumor therapy in the head and neck regions.

The bipolar RF electrode configuration limits the flow of current to the tip of the probe, enabling tissue to be treated with greater care and speed than in conventional thermotechnology. In contrast to monopolar RF techniques, which can cause irreversible damage to peripheral tissue by overheating, only the tissue in the immediate vicinity of the bipolar probe is exposed to the electric current.

In the treatment of nasal concha hyperplasia, for example, controlled regions of coagulation are generated within the concha with no risk of damaging the ciliated epithelium. In this process, the bipolar probe longitudinally pierces the hyperplastic nasal concha of the patient under local anesthesia. Activation of the generator produces a current in the probe, resulting in precise coagulation of the pathologic tissue in only three to five seconds. An acoustic feedback on the generator signals the degree of coagulation, culminating in an acoustic stop signal. This self-regulating property excludes any overdose or carbonizing effects in the treated tissue.

The RFITT system, under the name CelonENT, was developed by Celon AG (Berlin, Germany).



Related Links:
Celon AG

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.